Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Human platelets as a model for the binding and degradation of thrombopoietin.

Fielder PJ, Hass P, Nagel M, Stefanich E, Widmer R, Bennett GL, Keller GA, de Sauvage FJ, Eaton D.

Blood. 1997 Apr 15;89(8):2782-8.

PMID:
9108396
[PubMed - indexed for MEDLINE]
Free Article
2.

Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.

Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ.

Blood. 1996 Mar 15;87(6):2154-61.

PMID:
8630374
[PubMed - indexed for MEDLINE]
Free Article
3.

Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.

Li J, Xia Y, Kuter DJ.

Br J Haematol. 1999 Aug;106(2):345-56.

PMID:
10460590
[PubMed - indexed for MEDLINE]
4.

Human platelets display high-affinity receptors for thrombopoietin.

Broudy VC, Lin NL, Sabath DF, Papayannopoulou T, Kaushansky K.

Blood. 1997 Mar 15;89(6):1896-904.

PMID:
9058709
[PubMed - indexed for MEDLINE]
Free Article
5.

The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.

Li J, Xia Y, Kuter DJ.

Br J Haematol. 2000 Dec;111(3):943-53.

PMID:
11122159
[PubMed - indexed for MEDLINE]
6.

Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.

Scheding S, Bergmann M, Shimosaka A, Wolff P, Driessen C, Rathke G, Jaschonek K, Brugger W, Kanz L.

Transfusion. 2002 Mar;42(3):321-7.

PMID:
11961237
[PubMed - indexed for MEDLINE]
7.

Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.

Horikawa Y, Matsumura I, Hashimoto K, Shiraga M, Kosugi S, Tadokoro S, Kato T, Miyazaki H, Tomiyama Y, Kurata Y, Matsuzawa Y, Kanakura Y.

Blood. 1997 Nov 15;90(10):4031-8.

PMID:
9354672
[PubMed - indexed for MEDLINE]
Free Article
8.

Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?

Folman CC, Linthorst GE, van Mourik J, van Willigen G, de Jonge E, Levi M, de Haas M, von dem Borne AE.

Thromb Haemost. 2000 Jun;83(6):923-30.

PMID:
10896250
[PubMed - indexed for MEDLINE]
9.

Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice.

Stefanich E, Senn T, Widmer R, Fratino C, Keller GA, Fielder PJ.

Blood. 1997 Jun 1;89(11):4063-70.

PMID:
9166846
[PubMed - indexed for MEDLINE]
Free Article
10.

Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.

Sabath DF, Lin N, Sabath DE, Kaushansky K, Broudy VC.

Cytokine. 2000 Feb;12(2):127-33.

PMID:
10671297
[PubMed - indexed for MEDLINE]
11.

High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.

Cohen-Solal K, Vitrat N, Titeux M, Vainchenker W, Wendling F.

Blood. 1999 May 1;93(9):2859-66.

PMID:
10216080
[PubMed - indexed for MEDLINE]
Free Article
12.

Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.

Bunting S, Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore MW, Keller GA, de Sauvage FJ.

Blood. 1997 Nov 1;90(9):3423-9.

PMID:
9345025
[PubMed - indexed for MEDLINE]
Free Article
13.

Neutralization of biological activity and inhibition of receptor binding by antibodies against human thrombopoietin.

Tahara T, Kuwaki T, Matsumoto A, Morita H, Watarai H, Inagaki Y, Ohashi H, Ogami K, Miyazaki H, Kato T.

Stem Cells. 1998;16(1):54-60.

PMID:
9474748
[PubMed - indexed for MEDLINE]
Free Article
14.

Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.

Campus F, Lova P, Bertoni A, Sinigaglia F, Balduini C, Torti M.

J Biol Chem. 2005 Jul 1;280(26):24386-95. Epub 2005 Apr 29.

PMID:
15863506
[PubMed - indexed for MEDLINE]
Free Article
15.

Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.

Tamura H, Ogata K, Luo S, Nakamura K, Yokose N, Dan K, Tohyama K, Yoshida Y, Hamaguchi H, Sakamaki H, Kuwaki T, Tahara T, Kato T, Nomura T.

Br J Haematol. 1998 Dec;103(3):778-84.

PMID:
9858230
[PubMed - indexed for MEDLINE]
16.

Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.

Erhardt JA, Erickson-Miller CL, Aivado M, Abboud M, Pillarisetti K, Toomey JR.

Exp Hematol. 2009 Sep;37(9):1030-7. doi: 10.1016/j.exphem.2009.06.011. Epub 2009 Jul 24.

PMID:
19631713
[PubMed - indexed for MEDLINE]
17.

Expression of the soluble extracellular domain of human thrombopoietin receptor using a maltose-binding protein-affinity fusion system.

Zhang Q, Pan RM, Ge YC, Xu P.

Biol Pharm Bull. 2004 Feb;27(2):219-21.

PMID:
14758037
[PubMed - indexed for MEDLINE]
Free Article
18.

[Study of thrombopoietin and its receptor C-mpl in acute leukemia].

Guo Y, Bian S, Luo M.

Zhonghua Xue Ye Xue Za Zhi. 1999 Mar;20(3):120-3. Chinese.

PMID:
11601235
[PubMed - indexed for MEDLINE]
19.

A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.

Kimura T, Kaburaki H, Tsujino T, Ikeda Y, Kato H, Watanabe Y.

FEBS Lett. 1998 May 29;428(3):250-4.

PMID:
9654143
[PubMed - indexed for MEDLINE]
Free Article
20.

Thrombopoietin in vitro and in vivo.

Alexander WS, Begley CG.

Cytokines Cell Mol Ther. 1998 Mar;4(1):25-34. Review.

PMID:
9557214
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk